About Michael Lyman
Michael Lyman is an executive officer at AI3 Bio.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Lyman in the role, so the role may have started earlier or lasted longer.
AI3 Bio, Inc.
Executive officer
2026 · Watertown, MA
ai3Bio develops lipid nanoparticle and antibody drugs that remove the T cells driving autoimmune disease, for patients living with these conditions.
Key Colleagues at Startups
The people Michael Lyman works with at each company, as listed on that company's latest Form D.
AI3 Bio, Inc. · Form D, Nov 4, 2026
Steven Altschuler
CEO, Board Director
NS
Nick Seaver
CFO/CBO, Board Director
FT
Fabian Tenenbaum
Director
JC
Jeanne Cunicelli
Director
AE
Alan Ezekowitz
Board Director
Jonathan Kagan
Distinguished Scientist